4526 RIKEN VITAMIN CO.,LTD. - Financial Results

About Information Provided on This Site

The information provided on our website 'Kabutan.com' is not intended to constitute investment solicitation or investment advisory services.
All investment decisions should be made at your own discretion and judgment.
The data on our website is provided by Tokyo Stock Exchange, Osaka Exchange, Nagoya Securities Exchange, JPX Market Innovation & Research, Japannext, and other sources.
Copyright of the Nikkei Stock Average belongs to Nikkei Inc. Stock price charts displayed on Kabutan.com are provided solely for the purpose of reviewing historical price movements of the securities.
These charts neither suggest nor guarantee future price movements of the securities and do not constitute recommendations to buy or sell.
In our financial results coverage, the term 'Surprise Results' identifies securities that demonstrate a significant degree of surprise in their earnings announcements.
This significance is quantitatively assessed based on multiple factors, including: the nature of the announcement (full-year or quarterly results); types of revisions (earnings or dividend forecasts); and numerical analysis comparing the announced results with both the company's previous forecasts and historical performance.
The 'Surprise Ranking' presents these results in order of their calculated surprise factor. Please note that neither these results nor rankings are intended to suggest or guarantee future performance of the listed securities, nor should they be construed as recommendations to buy or sell.

4526

TSE Prime

RIKEN VITAMIN CO.,LTD.

2,889

JPY

(+0.28%)

Mar 16, 9:20 am JST

18.11

USD

Mar 15, 8:20 pm EDT

Result

PTS

outside of trading hours

2,887

Mar 16, 9:19 am JST

Summary Chart Historical News Financial Result

Current Period Guidance

Annual

Result

Guidance History

Growth Rate

Profitability

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
Mar, 2022	79,231	5,840	6,182	21,582	658.0	46	May 13, 2022	J-GAAP
Mar, 2023	88,750	7,158	7,723	6,414	195.5	59	May 12, 2023	J-GAAP
Mar, 2024	91,484	9,371	10,296	8,755	268.4	81	May 10, 2024	J-GAAP
Mar, 2025	95,582	8,724	9,417	9,388	310.1	94	May 14, 2025	J-GAAP
Mar, 2026 Guidance	96,000	6,200	7,000	6,500	222.4	110	Feb 12, 2026	J-GAAP
YoY	+0.4%	-28.9%	-25.7%	-30.8%	-28.3%

Revision Direction	Revision Date	Revenue	Operating Profit	Ordinary Profit	Net Profit	Revised Dividend	Accounting Standards
Mar, 2021	Sep 30, 2020	80,000	4,200	4,000	800	42*	J-GAAP
	Oct 28, 2020	78,000	2,000	1,800	-1,300	42*	J-GAAP
	Feb 15, 2021	78,000	1,100	1,000	-1,800	42*	J-GAAP
	May 12, 2021	77,720	1,360	1,650	-1,610	42*	J-GAAP
Results	May 14, 2021	77,722	1,367	1,652	-1,618	42*	J-GAAP
Mar, 2022	May 14, 2021	Available in future release
	Aug 6, 2021
	Nov 10, 2021
	Feb 10, 2022
	Apr 25, 2022
Results	May 13, 2022
Mar, 2023	May 13, 2022
	Aug 10, 2022
	Feb 10, 2023
Results	May 12, 2023
Mar, 2024	May 12, 2023
	Nov 10, 2023
	Feb 9, 2024
Results	May 10, 2024
Mar, 2025	May 10, 2024
	Feb 14, 2025
Results	May 14, 2025
Mar, 2026	May 14, 2025	100,000	8,500	9,000	8,200	110	J-GAAP
	Feb 12, 2026	96,000	6,200	7,000	6,500	110	J-GAAP

Fiscal Year	Revenue	YoY	Operating Profit	YoY	Ordinary Profit	YoY	Adj. EPS	YoY
Mar, 2001	69,110	+3.2	Available in future release
Mar, 2002	68,854	-0.4
Mar, 2003	68,412	-0.6
Mar, 2004	70,752	+3.4
Mar, 2005	73,770	+4.3
Mar, 2006	79,011	+7.1
Mar, 2007	80,821	+2.3
Mar, 2008	80,842	0.0
Mar, 2009	78,915	-2.4
Mar, 2010	76,550	-3.0
Mar, 2011	77,912	+1.8
Mar, 2012	75,398	-3.2
Mar, 2013	77,568	+2.9
Mar, 2014	85,419	+10.1
Mar, 2015	85,603	+0.2
Mar, 2016	88,072	+2.9
Mar, 2017	87,181	-1.0
Mar, 2018	89,515	+2.7
Mar, 2019	89,024	-0.5
Mar, 2020	82,974	-6.8
Mar, 2021	77,722	-6.3
Mar, 2022	79,231	+1.9
Mar, 2023	88,750	+12.0
Mar, 2024	91,484	+3.1
Mar, 2025	95,582	+4.5
Mar, 2026 Guidance	96,000	+0.4	6,200	-28.9	7,000	-25.7	222.4	-28.3

Fiscal Year	Revenue	Operating Profit	Operating Profit Margin	ROE	ROA	Total Asset Turnover Ratio	Adj. EPS
Mar, 2024	91,484	9,371	10.2	11.83	7.82	0.82	268.4
Mar, 2025	95,582	8,724	9.13	12.05	8.10	0.82	310.1
Mar, 2026 Guidance	96,000	6,200	6.46	7.93	5.57	0.82	222.4

All-Time High

	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS
Record	95,582	9,371	10,296	21,582	658.0
Fiscal Year	Mar, 2025	Mar, 2024	Mar, 2024	Mar, 2022	Mar, 2022

Second Half

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
Oct - Mar, 2022	45,119	3,601	3,574	3,268	99.6	36	May 12, 2023	J-GAAP
Oct - Mar, 2023	46,871	4,775	5,076	5,088	156.0	50.50	May 10, 2024	J-GAAP
Oct - Mar, 2024	48,433	4,098	4,631	6,133	202.6	53.50	May 14, 2025	J-GAAP
Oct - Mar, 2025 Guidance	48,735	2,109	2,632	3,139	107.4	55	Feb 12, 2026	J-GAAP
YoY	+0.6%	-48.5%	-43.2%	-48.8%	-47.0%

Cash Flow

Annual

Fiscal Year	Operating Profit	Fee Cash Flow	Operating Cash Flow	Investing Cash Flow	Financial Cash Flow	Cash & Equivalents	Cash Ratio	Accounting Standards
Mar, 2023	7,158	5,801	7,835	-2,034	-4,578	16,656	15.83	J-GAAP
Mar, 2024	9,371	9,897	10,451	-554	-7,084	20,141	16.96	J-GAAP
Mar, 2025	8,724	8,245	7,892	353	-9,965	18,835	16.67	J-GAAP

Actual Performance and Financial Trends

Accumulated Results 3rd Quarter

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Progress Rate vs. First Half	Announce	Accounting Standards
Apr - Dec, 2023	69,058	7,660	8,396	6,080	185.3	81.5	Feb 9, 2024	J-GAAP
Apr - Dec, 2024	72,852	7,544	8,241	5,834	192.2	87.5	Feb 14, 2025	J-GAAP
Apr - Dec, 2025	72,503	5,716	6,403	5,949	200.8	91.5	Feb 12, 2026	J-GAAP
YoY	-0.5%	-24.2%	-22.3%	+2.0%	+4.5%

Quarterly Results

Result

Growth Rate

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Operating Profit Margin	Announce	Accounting Standards
Jan - Mar, 2024	22,426	1,711	1,900	2,675	82.0	7.6	May 10, 2024	J-GAAP
Apr - Jun, 2024	23,626	2,522	2,927	2,370	78.1	10.7	Aug 9, 2024	J-GAAP
Jul - Sep, 2024	23,523	2,104	1,859	885	29.2	8.9	Nov 13, 2024	J-GAAP
Oct - Dec, 2024	25,703	2,918	3,455	2,579	85.0	11.4	Feb 14, 2025	J-GAAP
Jan - Mar, 2025	22,730	1,180	1,176	3,554	117.4	5.2	May 14, 2025	J-GAAP
Apr - Jun, 2025	23,257	2,365	2,531	1,825	61.2	10.2	Aug 8, 2025	J-GAAP
Jul - Sep, 2025	24,008	1,726	1,837	1,536	51.7	7.2	Nov 13, 2025	J-GAAP
Oct - Dec, 2025	25,238	1,625	2,035	2,588	87.3	6.4	Feb 12, 2026	J-GAAP
YoY	-1.8%	-44.3%	-41.1%	+0.3%	+2.8%

Fiscal Year	Revenue	YoY	Operating Profit	YoY	Ordinary Profit	YoY	Adj. EPS	YoY
Jan - Mar, 2021	18,617	-6.3	Available in future release
Apr - Jun, 2021	19,500	+5.7
Jul - Sep, 2021	19,103	-2.1
Oct - Dec, 2021	20,983	-0.8
Jan - Mar, 2022	19,645	+5.5
Apr - Jun, 2022	21,569	+10.6
Jul - Sep, 2022	22,062	+15.5
Oct - Dec, 2022	23,672	+12.8
Jan - Mar, 2023	21,447	+9.2
Apr - Jun, 2023	22,189	+2.9
Jul - Sep, 2023	22,424	+1.6
Oct - Dec, 2023	24,445	+3.3
Jan - Mar, 2024	22,426	+4.6
Apr - Jun, 2024	23,626	+6.5
Jul - Sep, 2024	23,523	+4.9
Oct - Dec, 2024	25,703	+5.1
Jan - Mar, 2025	22,730	+1.4
Apr - Jun, 2025	23,257	-1.6
Jul - Sep, 2025	24,008	+2.1
Oct - Dec, 2025	25,238	-1.8	1,625	-44.3	2,035	-41.1	87.3	+2.7

All-Time High Quarterly Results

	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS
Record	25,703	3,064	3,455	15,668	477.8
Fiscal Year	Dec, 2024	Dec, 2023	Dec, 2024	Jun, 2021	Jun, 2021

Key Balance Sheet Figures

Fiscal Year	BPS	Equity Ratio	Total Asset	Equity	Retained Earnings	Interest-Bearing Debt Ratio	Announce	Accounting Standards
Mar, 2023	2,174.39	67.8	105,223	71,345	58,729	0.20	May 12, 2023	J-GAAP
Mar, 2024	2,523.84	64.5	118,776	76,613	65,290	0.21	May 10, 2024	J-GAAP
Mar, 2025	2,649.95	70.1	112,999	79,163	64,774	0.13	May 14, 2025	J-GAAP
Apr - Dec, 2025	ー	70.2	116,694	81,937	67,478	0.10	Feb 12, 2026	J-GAAP

RIKEN VITAMIN CO.,LTD.(4526) Financial Results